Showing results (611-620 of 2,363) with videos related to

Sort By:
Pageof 237
Future Medicinal Chemistry|November 13, 2013
5-alkyl-1,3-oxazole derivatives of 6-amino-nicotinic acids as alkyl ester bioisosteres are antagonists of the P2Y12 receptorPeter Bach, Jonas Boström, Kay Brickmann, et al.
Future Medicinal Chemistry|March 31, 2012
Virtual compound screening in drug discoveryDagmar Stumpfe, Peter Ripphausen, Jürgen Bajorath
Future Medicinal Chemistry|November 23, 2013
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptaseAngela Corona, Takashi Masaoka, Graziella Tocco, et al.
Future Medicinal Chemistry|November 23, 2013
Targeting protein arginine N-methyltransferases with peptide-based inhibitors: opportunities and challengesMynol Vhuiyan, Dylan Thomas, Farhad Hossen, et al.
Future Medicinal Chemistry|April 26, 2012
Sphingosine kinase and sphingosine-1-phosphate receptors: novel therapeutic targets of rheumatoid arthritis?Wen-Qi Lai, Faith Li-Ann Chia, Bernard P Leung
Future Medicinal Chemistry|April 26, 2012
PBEF/NAMPT/visfatin: a promising drug target for treating rheumatoid arthritis?Mari Nowell, Laura Evans, Anwen Williams
Future Medicinal Chemistry|September 19, 2015
Concise postsynthetic preparation of oligonucleotide-oligopeptide conjugates through facile disulfide bond formationMehrdad Dirin, Ernst Urban, Bodo Lachmann, et al.
Future Medicinal Chemistry|September 19, 2015
Mechanistic principles of antisense targets for the treatment of spinal muscular atrophyNatalia N Singh, Brian M Lee, Christine J DiDonato, et al.
Future Medicinal Chemistry|June 3, 2016
Discovery of the first small-molecule CsrA-RNA interaction inhibitors using biophysical screening technologiesChristine K Maurer, Martina Fruth, Martin Empting, et al.
Future Medicinal Chemistry|August 10, 2017
Targeting species-specific trace amine-associated receptor 1 ligands: to date perspective of the rational drug design processElena Cichero, Michele Tonelli
Pageof 237